Mineralocorticoid receptor antagonists for chronic central serous chorioretinopathy: systematic review and meta-analyses.

Camila Q FelipeAna Luiza BiancardiVinicius T CivileNelson Carvas JuniorPedro D SerracarbassaMarcia Kiyomi Koike

Published in: International journal of retina and vitreous (2022)

MRAs have little to no effect on BCVA. Evidence for adverse events and CST is very uncertain. MRAs also have little to no effect on SFH and CCT. These findings should be considered when prescribing MRAs for cCSCR. This research was previous registration in the PROSPERO platform (CRD42020182601).

Keyphrases

meta analyses
systematic review
primary care
randomized controlled trial
high throughput
emergency department
single cell
electronic health record